When Will Ozempic Go Generic? The Honest Timeline
There is no FDA-approved generic version of Ozempic yet, and compounded is not a generic. Here is the honest picture.
The short answer
As of 2026 there is no FDA-approved generic version of Ozempic or Wegovy. Semaglutide is still protected by patents that are generally expected to extend into roughly the early 2030s, and timing can shift with litigation and settlements. When a true generic does arrive, it will be FDA-approved and interchangeable, unlike compounded semaglutide.
Compounded is not a generic
This is the most important distinction. The dispensing pharmacy label identifies the compounded preparation as semaglutide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. It is a different category that exists for access reasons, not a cheaper approved copy of the brand.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trialWhat this means for you now
Waiting indefinitely for a generic is not a plan for most people who qualify for treatment today. The realistic, honest options now are brand medication (often expensive without coverage) or physician-supervised compounded semaglutide, with the trade-offs clearly explained.
How this relates to what we offer
We offer physician-supervised compounded semaglutide from $166 a month after a $119 review, and we are explicit that it is not FDA-approved, not brand-identical, and not a generic.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.
Frequently asked questions
Is there a generic version of Ozempic?
No. As of 2026 there is no FDA-approved generic of Ozempic or Wegovy. Semaglutide remains under patent, generally expected to extend into roughly the early 2030s.
Is compounded semaglutide the same as a generic?
No. The dispensing pharmacy label identifies the compounded preparation as semaglutide. It is a different product from FDA-approved brands, is not FDA-approved or brand-identical, and results vary. It is a separate category.
When will a generic actually arrive?
Exact timing is uncertain and depends on patents, litigation, and settlements; estimates point to roughly the early 2030s. A real generic will be FDA-approved when it comes.
Should I wait for a generic?
For most people who qualify now, waiting years is not practical. A physician can discuss brand vs compounded options and the honest trade-offs of each.
Why is brand Ozempic so expensive?
It is a patent-protected, newer medication. Until a generic is approved, brand pricing stays high, which is part of why compounded options exist for access.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.